Avila Cesar O
Department of Emergency Medicine, San Diego Medical Center, CA.
Perm J. 2019;23. doi: 10.7812/TPP/19-025. Epub 2019 Jun 27.
Early recognition and treatment of ST-elevation myocardial infarction (STEMI) results in better outcomes.
To describe a novel technique using the Apple Watch 4 (Apple Inc, Cupertino, CA) to obtain a 3-lead electrocardiogram (ECG) and confirm the watch's feasibility to detect cardiac ischemia in selective cases with a particular injury pattern.
Two male patients in the Emergency Department had STEMI apparent on their ECGs. These findings were compared with those from the Apple Watch 4, whose positioning was adjusted for 3-lead ECG.
The patients' real-time, watch-based, 3-lead ECG tracings matched the traditional ECGs demonstrating STEMI, confirming the potential ability of this device to uncover myocardial ischemia. In each patient, cardiac catheterization revealed severe, 100% occlusion of the right coronary artery.
The Apple Watch 4 could lead to earlier detection of acute coronary artery disease, but sensitivity and specificity remain unknown.
ST段抬高型心肌梗死(STEMI)的早期识别和治疗可带来更好的预后。
描述一种使用苹果手表4(苹果公司,加利福尼亚州库比蒂诺)获取三导联心电图(ECG)的新技术,并确认该手表在特定损伤模式的选择性病例中检测心肌缺血的可行性。
急诊科的两名男性患者心电图显示为STEMI。将这些结果与苹果手表4的结果进行比较,该手表的位置已针对三导联心电图进行了调整。
基于手表的患者实时三导联心电图描记与显示STEMI的传统心电图相匹配,证实了该设备发现心肌缺血的潜在能力。在每位患者中,心脏导管检查显示右冠状动脉严重闭塞,闭塞率达100%。
苹果手表4可能会导致急性冠状动脉疾病的更早检测,但敏感性和特异性仍未知。